R. Hector MacKay-Dunn

AUPH

R. Hector MacKay-Dunn serves as Director at Aurinia Pharmaceuticals Inc. (AUPH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$105.5K

Total Sells

2 trades

$86.6K

Net Position

Net Buyer

$18.9K

Companies Traded

AUPH

Active Period

May 2021 – May 2024

4 total trades

Most Recent

Sell AUPH

May 21, 2024 · $32.3K

R. Hector MacKay-Dunn's Insider Trading at Aurinia Pharmaceuticals Inc. (AUPH)

Buys

2 · $105.5K

Sells

2 · $86.6K

Total Shares Bought

9,500

Total Shares Sold

10,448

AUPH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
May 21, 2024	Sell	5,630	$5.74	$32.3K
May 18, 2023	Sell	4,818	$11.26	$54.3K
Mar 9, 2022	Buy	5,000	$11.00	$55.0K
May 11, 2021	Buy	4,500	$11.23	$50.5K

Related Insiders

Joseph M Miller

Chief Financial Officer

AUPHSell · Feb 20, 2026

Stephen P. Robertson

EVP, General Counsel

AUPHSell · Feb 20, 2026

Peter Greenleaf

Chief Executive Officer

AUPHSell · Feb 20, 2026

Matthew Maxwell Donley

Chief Operating Officer

AUPHSell · Feb 20, 2026

Greg Keenan

SVP, Chief Medical Officer

AUPHSell · Feb 2, 2026

Jeffrey Allen Bailey

Director

AUPHSell · Nov 21, 2025

Craig A Johnson

Director

AUPHSell · Nov 21, 2025

TANG KEVIN

Director

AUPHBuy · Aug 1, 2025

Explore More Insider Trading Data

AUPH Insider Trading Activity

View all insider trades at Aurinia Pharmaceuticals Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity